Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02225769
Other study ID # IZ01Z0_146896
Secondary ID
Status Completed
Phase N/A
First received August 22, 2014
Last updated October 11, 2016
Start date December 2014
Est. completion date February 2016

Study information

Verified date October 2016
Source Swiss Tropical & Public Health Institute
Contact n/a
Is FDA regulated No
Health authority Tanzania: National Institute for Medical Research
Study type Interventional

Clinical Trial Summary

Health professionals in developing countries have limited ability to identify children at risk of dying and those in need of antibiotics. The main reasons are limited clinical skills and time, unavailability of diagnostic tests (laboratory or x-ray) and non-adherence to practice guidelines. Child mortality is therefore higher than it should be. Etiological diagnostic tests (detecting microorganisms) may not always help since the distinction between infection and disease and between mild or severe disease is not straightforward. Overprescription of antibiotics is therefore widespread and leads to the development of drug resistance. To address these challenges, decision charts for the management of febrile illness will be developed and include i) few clinical parameters simple to assess, and ii) POCTs results based on specific host markers that can discriminate between mild and severe disease, pneumonia and upper respiratory tract infections, and unspecific fevers of bacterial and of viral origin. This algorithm combining clinical and bedside laboratory tests will be built on an electronic support (android tablet). The first objective of the study is to assess the safety of new electronic decision trees that integrate simple clinical assessment and POCTs results (oxygen saturation and a combination of specific biomarkers of inflammation) as a triage tool to decide on admitting febrile children; the second objective is to assess the usefulness and safety of new electronic decision trees that integrate simple clinical assessment and POCT results (a combination of specific biomarkers of inflammation) as decision-making tool to prescribe antibiotics to non-severe febrile children. The development of such a tool will decrease mortality due to delayed admission, At the same time, it will decrease irrational use of antibiotics, and hence drug pressure and emergence of drug resistance, which represents one of the most important public health threat our world is facing today. This project has the potential of huge applicability since it is specifically designed for end-users with limited medical skills and low resources, as it is the case in most areas of developing countries.


Recruitment information / eligibility

Status Completed
Enrollment 3192
Est. completion date February 2016
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender Both
Age group 2 Months to 59 Months
Eligibility Inclusion Criteria:

- Age =2 months and <60 months of age

- Written informed consent from the child's parent or caregiver

- Axillary temperature =37.5°C and/or tympanic temperature =38.0°C

- History of fever for =7 days

- First consultation for the current illness

- Live in the catchment area of the health facility

Exclusion Criteria:

- Age 60 months or greater

- Age less than 2 months

- Weight less than 2.5kg

- Chief health problem is an injury, trauma or acute poisoning

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
Management of febrile children using e-POCT
Use of the e-POCT tool by study clinicians for the clinical management of febrile episodes. The e-POCT tool is an electronic algorithm that integrates key clinical elements with the results of malaria and host biomarkers point-of-care test results (including oximetry).
Management of febrile children using ALMANACH
Management of febrile children by study clinicians using ALMANACH. ALMANACH is an improved IMCI algorithm on mobile phone or tablet

Locations

Country Name City State
Tanzania Rangi tatu, Magomeni and Tandale health centers Dar es Salaam

Sponsors (2)

Lead Sponsor Collaborator
Swiss Tropical & Public Health Institute Swiss National Science Foundation

Country where clinical trial is conducted

Tanzania, 

Outcome

Type Measure Description Time frame Safety issue
Other Diagnostic performance of combinations of host biomarkers in identifying children at risk for life-threatening infections and for clinical failure among children presenting with fever (e-POCT and ALMANACH arms). The objective is to explore the performance of combinations of host biomarkers in identifying children in need for antibiotic treatment, by type of infection (ALMANACH arm). 22 months No
Primary Proportion of clinical failure by day 7 compared among the 3 study arms. This outcome measure is used to compare the clinical outcome of febrile children 2-59 months of age managed using e-POCT (intervention arm), ALMANACH (reference control arm) and routine practice (routine control arm). 10 months Yes
Secondary Proportions of secondary hospitalization and death by day 30 compared among the 3 study arms. This outcome measure is also used to compare the clinical outcome of febrile children 2-59 months of age managed using e-POCT (intervention arm), ALMANACH (reference control arm) and routine practice (routine control arm). This type of event is however too rare to be used as primary endpoint. 10 months Yes
Secondary Proportions of children prescribed an antibiotic and/or antimalarial treatment at day 0 and by day 7 compared among the 3 study arms. This outcome is used to compare the rational use of antimicrobials in treating febrile children using e-POCT, ALMANACH and routine care. 10 months No
Secondary Proportions of children with hypoxemia, stratified by diagnostic classification (e-POCT arm) The aim is to measure the proportion of febrile children with hypoxemia, stratified by diagnostic classification (e-POCT arm only). 10 months No
Secondary Proportion of primarily admitted children compared among the 3 study arms. The objective is to compare the performance of e-POCT, ALMANACH and routine care in identifying children at risk for life-threatening infection among febrile children. 10 months Yes
See also
  Status Clinical Trial Phase
Completed NCT03943654 - Improving Nighttime Access to Care and Treatment (Part 2)
Completed NCT04299412 - Diagnostic Accuracy of the DPP II Assay
Completed NCT04299607 - Evaluation of the DPP II Assay in Laos
Recruiting NCT05050825 - Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal N/A
Recruiting NCT04878549 - Transcriptomic Responses for the Identification of Pathogens
Recruiting NCT04629053 - Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia
Completed NCT04268732 - Acute Undifferentiated Fever in Ethiopia
Completed NCT02763462 - The Etiology of Acute Febrile Illness Requiring Hospitalization
Recruiting NCT05292508 - Comparison of Rates of Antimicrobial Use in Febrile Patients With or Without the Use of C-reactive Protein Blood Test N/A
Completed NCT01403350 - Cluster Randomised Trial of Malaria RDTs Used by CHWs in Afghanistan Phase 4
Completed NCT04081051 - Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention N/A